Related references
Note: Only part of the references are listed.Myelodysplastic Syndromes, Version 3.2022 Featured Updates to the NCCN Guidelines
Peter L. Greenberg et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Insight into the Molecular Basis Underlying Chromothripsis
Katarzyna Ostapinska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Unique morphologic and genetic characteristics of acute myeloid leukemia with chromothripsis: a clinicopathologic study from a single institution
Juehua Gao et al.
HUMAN PATHOLOGY (2020)
Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome
Cecilia C. S. Yeung et al.
MODERN PATHOLOGY (2018)
Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome
Fernanda Borges Da Silva et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China
Qinyong Hu et al.
ANNALS OF HEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance
Andrew G. Evans et al.
MODERN PATHOLOGY (2016)
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes
Maria Abaigar et al.
PLOS ONE (2016)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
M. G. Della Porta et al.
LEUKEMIA (2015)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
Ramon V. Tiu et al.
BLOOD (2011)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p
M. Jasek et al.
LEUKEMIA (2010)
FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)
Hideki Makishima et al.
LEUKEMIA RESEARCH (2010)
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
Anna M. Jankowska et al.
BLOOD (2009)
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies
Jaroslaw P. Maciejewski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
Hideki Makishima et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics
S. Heinrichs et al.
LEUKEMIA (2009)
Cytogenetic Abnormalities in a Series of 1029 Patients With Primary Myelodysplastic Syndromes A Report From the US With a Focus on Some Undefined Single Chromosomal Abnormalities
Olga Pozdnyakova et al.
CANCER (2008)
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
Andrew J. Dunbar et al.
CANCER RESEARCH (2008)
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
Lukasz P. Gondek et al.
BLOOD (2008)
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients
Detlef Haase et al.
BLOOD (2007)
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali et al.
BLOOD (2007)
Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes
Lukasz P. Gondek et al.
EXPERIMENTAL HEMATOLOGY (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS
L. P. Gondek et al.
LEUKEMIA (2007)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
R Kralovics et al.
EXPERIMENTAL HEMATOLOGY (2002)
Share Paper
